Skip to content
The Policy VaultThe Policy Vault

Lumakras (sotorasib tablets - Amgen) — Cigna

Non-Small Cell Lung Cancer (NSCLC)

Initial criteria

  • Patient age ≥ 18 years
  • Patient has KRAS G12C-mutated locally advanced or metastatic NSCLC, as determined by an approved test
  • Patient has been previously treated with at least one systemic regimen

Approval duration

1 year